title: Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience.
authors.forename: V V
authors.initials: VV
authors.lastname: Kaushik
authors.forename: S
authors.initials: S
authors.lastname: Ambalavanan
authors.forename: K
authors.initials: K
authors.lastname: Binymin
mesh_terms: D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007121:Immunocompetence; D008297:Male; D008403:Mass Screening / Q000458:organization & administration; D018579:Patient Selection; D011247:Pregnancy; D012680:Sensitivity and Specificity; D014376:Tuberculosis / Q000175:diagnosis*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha